Olivier Loeillot

Olivier Loeillot

Chief Executive Officer at REPLIGEN CORPORATION

Net worth: 8 M $ as of 2026-10-30

56 year
Health Technology
Finance
Commercial Services

Profile

Olivier Dominique Loeillot is President, Chief Executive Officer & Director at Repligen Corp.
since 2024.
Formerly, Mr. Loeillot was Chief Executive Officer at Ascensus Specialties LLC from 2022 to 2023, Director at Cytiva Bioscience Holding Ltd. from 2020 to 2022, Senior Vice President Bioprocess Division at Cytiva CTH Holding Ltd. from 2017 to 2020, VP Sales LONZA at Lonza AG from 2008 to 2010, Sales Director at Rhodia Pharma Solutions Ltd. from 2002 to 2003, and held roles as Director at Puridify Ltd., Management Partner at New Mountain Capital LLC, and other positions.
Mr. Loeillot earned an MBA from Emlyon Business School in 1994.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-10-04 45,788 ( 0.07% ) 8 M $ 2026-10-30

Olivier Loeillot active positions

CompaniesPositionStart
REPLIGEN CORPORATION Chief Executive Officer 2024-08-31

Former positions of Olivier Loeillot

CompaniesPositionEnd
Chief Executive Officer 2023-05-31
Director/Board Member 2022-08-31
Corporate Officer/Principal 2020-03-31
Sales & Marketing 2010-08-31
Private Equity Investor 2003-05-31
See the detail of Olivier Loeillot's experience

Education of Olivier Loeillot

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

39

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Finance

Health Technology

Health Technology

Commercial Services

Consumer Services

Process Industries

Finance

Finance

  1. Stock Market
  2. Insiders
  3. Olivier Loeillot